Huawei announced the Sense G1, its first continuous glucose monitoring device designed to track blood sugar levels and transmit data directly to smartphones or smartwatches, as reported by Mobilissimo on Friday.
The device applies directly to the arm as a separate sensor rather than functioning as a software update for existing wearables. Mobilissimo reported that the teaser from Huawei confirms permanent monitoring and alerts for abnormal values.
A continuous glucose monitor reads glucose from the interstitial fluid between cells rather than reading blood directly. The sensor positioned beneath the skin transmits this data wirelessly to a paired device so the user can observe the current value and directional trends.
Huawei secured Class III medical device certification in China for the product, representing the highest category in that regulatory system. Mobilissimo reported that this certification does not automatically constitute authorization within Romania or the wider European Union.
No announcements exist regarding a CE mark, medical system reimbursement, local app compatibility, or a European release date. Mobilissimo said that the official teaser confirmed permanent monitoring and anomaly alerts while withholding the complete technical specification sheet, pricing, and sales timeline.
Huawei smartwatches like the Watch 4 and Watch GT can estimate the risk of elevated blood sugar from physiological data without measuring actual glucose. Mobilissimo reported that the Sense G1 differs fundamentally by operating as a physical sensor applied to the arm instead of relying solely on optical smartwatch sensors.
The American Diabetes Association explains that readings from such sensors can show a slight delay compared to blood glucose measured from a fingertip, particularly following meals, physical exertion, or periods of rapid fluctuation.
